Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
Levi & Korsinsky Notifies Verve Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VERV
10:30am, Wednesday, 09'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If you suffe
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics, Inc. Lawsuit - VERV
10:15am, Wednesday, 09'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm
10:00am, Wednesday, 09'th Oct 2024
LOS ANGELES , Oct. 9, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Verve"
October 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VERV
07:15am, Wednesday, 09'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
NEW YORK CITY, NY / ACCESSWIRE / October 9, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Verve The
Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join – Contact Levi & Korsinsky
09:15pm, Tuesday, 08'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc. (VERV) of a Class Action Lawsuit and an Upcoming Deadline
01:19pm, Tuesday, 08'th Oct 2024
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Verve Therapeutics, Inc. (NASDAQ: VERV).
VERV LAWSUIT ALERT: Levi & Korsinsky Notifies Verve Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
11:30am, Tuesday, 08'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Verve Therapeutics, Inc.
11:00am, Tuesday, 08'th Oct 2024
LOS ANGELES, CA / ACCESSWIRE / October 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Verv
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Verve Therapeutics, Inc. (VERV) Shareholders
10:45am, Tuesday, 08'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 a
October 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VERV
07:15am, Tuesday, 08'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 8, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities
